Ann: Nuheara Q2 FY24 Business Update, page-3

So did I hear this right:

FDA approval quite some time away

Not manufacturing them til they know they will be approved?

OEMs will not commit until they see it manufactured and/or approved?

OEMs for other unregulated markets effectively dead

licensing arrangements dead until gen 4 manufactured?

How will a credit raise be avoided in the coming weeks? Could
be multiple raises required before any commercial terms arise that they could secure debt against?